Guofeng Qian

1.4k total citations
27 papers, 1.1k citations indexed

About

Guofeng Qian is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Guofeng Qian has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Guofeng Qian's work include Ferroptosis and cancer prognosis (9 papers), Renal cell carcinoma treatment (7 papers) and Renal and related cancers (5 papers). Guofeng Qian is often cited by papers focused on Ferroptosis and cancer prognosis (9 papers), Renal cell carcinoma treatment (7 papers) and Renal and related cancers (5 papers). Guofeng Qian collaborates with scholars based in China, United States and Germany. Guofeng Qian's co-authors include Yu Xiao, Xinghuan Wang, Gang Wang, Lushun Yuan, Rui Cao, Kaiyu Qian, Chin‐Lee Wu, Han C. Dan, Yongzhi Wang and Liang Chen and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Guofeng Qian

27 papers receiving 1.0k citations

Peers

Guofeng Qian
Manjula Karpurapu United States
Xin Ma China
Xue Leng China
Aiqin Cao United States
Guofeng Qian
Citations per year, relative to Guofeng Qian Guofeng Qian (= 1×) peers Yidong Yang

Countries citing papers authored by Guofeng Qian

Since Specialization
Citations

This map shows the geographic impact of Guofeng Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guofeng Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guofeng Qian more than expected).

Fields of papers citing papers by Guofeng Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guofeng Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guofeng Qian. The network helps show where Guofeng Qian may publish in the future.

Co-authorship network of co-authors of Guofeng Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Guofeng Qian. A scholar is included among the top collaborators of Guofeng Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guofeng Qian. Guofeng Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qian, Guofeng, et al.. (2022). A novel AIRE mutation leads to autoimmune polyendocrine syndrome type-1. Frontiers in Cell and Developmental Biology. 10. 948350–948350. 2 indexed citations
2.
Meng, Zhe, Liang Zhou, Zhe Dai, et al.. (2020). The Quality of Clinical Practice Guidelines and Consensuses on the Management of Primary Aldosteronism: A Critical Appraisal. Frontiers in Medicine. 7. 136–136. 2 indexed citations
4.
Luo, Yongwen, Liang Chen, Gang Wang, et al.. (2019). PPARα gene is a diagnostic and prognostic biomarker in clear cell renal cell carcinoma by integrated bioinformatics analysis. Journal of Cancer. 10(10). 2319–2331. 10 indexed citations
5.
Liang, Chen, Lushun Yuan, Kaiyu Qian, et al.. (2018). Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis. Frontiers in Physiology. 9. 399–399. 60 indexed citations
6.
Yuan, Lushun, Guofeng Qian, Liang Chen, et al.. (2018). Co-expression Network Analysis of Biomarkers for Adrenocortical Carcinoma. Frontiers in Genetics. 9. 328–328. 40 indexed citations
7.
Chen, Liang, Yongwen Luo, Gang Wang, et al.. (2018). Prognostic value of a gene signature in clear cell renal cell carcinoma. Journal of Cellular Physiology. 234(7). 10324–10335. 23 indexed citations
8.
Chen, Liang, Lushun Yuan, Yongzhi Wang, et al.. (2017). Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma. International Journal of Biological Sciences. 13(11). 1361–1372. 96 indexed citations
9.
Cao, Rui, Gang Wang, Kaiyu Qian, et al.. (2017). Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPARγ-SIRT1 feedback loop. Journal of Cancer. 8(12). 2282–2295. 31 indexed citations
10.
Chen, Liang, Rui Cao, Gang Wang, et al.. (2017). Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial–mesenchymal transition in prostate cancer cells. Medical Oncology. 34(7). 127–127. 34 indexed citations
11.
Yuan, Lushun, Liang Chen, Kaiyu Qian, et al.. (2017). Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC). Genomics Data. 14. 132–140. 69 indexed citations
12.
Chen, Liang, Lushun Yuan, Gang Wang, et al.. (2017). Identification and bioinformatics analysis of miRNAs associated with human muscle invasive bladder cancer. Molecular Medicine Reports. 16(6). 8709–8720. 13 indexed citations
13.
Cao, Rui, Gang Wang, Kaiyu Qian, et al.. (2017). TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARγ-SIRT1 feedback loop in human bladder cancer cells. Cancer Letters. 414. 278–293. 69 indexed citations
14.
Chen, Liang, Gang Wang, Yi Luo, et al.. (2016). Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells. International Journal of Oncology. 50(1). 263–271. 35 indexed citations
15.
Qian, Kaiyu, Gang Wang, Rui Cao, et al.. (2016). Capsaicin Suppresses Cell Proliferation, Induces Cell Cycle Arrest and ROS Production in Bladder Cancer Cells through FOXO3a-Mediated Pathways. Molecules. 21(10). 1406–1406. 45 indexed citations
16.
Cao, Rui, Zhe Meng, Tongzu Liu, et al.. (2016). DecreasedTRPM7inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway. Oncotarget. 7(45). 72941–72960. 59 indexed citations
17.
Wang, Gang, Rui Cao, Yongzhi Wang, et al.. (2016). Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway. Scientific Reports. 6(1). 35783–35783. 103 indexed citations
18.
Qian, Guofeng, Wei Fan, Barbara Ahlemeyer, Srikanth Karnati, & Eveline Baumgart‐Vogt. (2015). Peroxisomes in Different Skeletal Cell Types during Intramembranous and Endochondral Ossification and Their Regulation during Osteoblast Differentiation by Distinct Peroxisome Proliferator-Activated Receptors. PLoS ONE. 10(12). e0143439–e0143439. 22 indexed citations
19.
Xiao, Yu, Srikanth Karnati, Guofeng Qian, et al.. (2012). Cre-Mediated Stress Affects Sirtuin Expression Levels, Peroxisome Biogenesis and Metabolism, Antioxidant and Proinflammatory Signaling Pathways. PLoS ONE. 7(7). e41097–e41097. 27 indexed citations
20.
Zhang, Xiuzhen, et al.. (2006). [Effects of alendronate on bone mineral density, cytokines and indices of bone metabolism in postmenopausal osteoporotic patients].. PubMed. 45(7). 565–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026